Hotel Palace Berlin Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

NOTES:
This meeting occurs in 2018.
This meeting will be conducted in English.

All programs are subject to change. Check this site for updates.


This meeting is part of the Global Health Series

Download Flyer

21st Century Drug Discovery & Development for Global Health (S3)

Scientific Organizers: Ken Duncan, Elizabeth Winzeler and Lluis Ballell


October 17—20, 2018

Hotel Palace Berlin, Berlin, Germany


Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation


BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

** Registration currently unavailable **



Discounted Abstract Deadline: June 19, 2018


Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is July 17, 2018)

Global Health Travel Award Deadline:


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: June 19, 2018


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: July 17, 2018


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is June 19, 2018)

Discounted Registration Deadline: August 16, 2018


Registration Fee: 895.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 670.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1095.00 USD*
Student Registration Fee: 870.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Wednesday, October 17 with registration from 16:00 to 20:00 and a welcome mixer from 18:30 to 20:00. Conference events conclude on Saturday, October 20 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Sunday, October 21 in order to fully experience the meeting.

WEDNESDAY, OCTOBER 17

16:00—20:00
Arrival and Registration

18:30—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.


THURSDAY, OCTOBER 18

08:30—10:00
New Therapeutics for Global Health
Registered attendees can view abstracts starting on 09/17/2018

Nathalie Strub Wourgaft, Drugs for Neglected Diseases initiative, DNDi, Switzerland
Transformative New Therapies for Human African trypanosomiasis

Thierry T. Diagana†, Novartis Institute for Tropical Diseases, Singapore
Progress with Cipargamin and KAF156 in Phase 2 Development for Treatment of Malaria

Lluis Ballell, GlaxoSmithKline, Spain
Novel Drug Candidates to Address the Threat of Antibacterial Resistance in the Developing World; TB and Shigella

Short Talk(s) Chosen from Abstracts

10:20—12:00
Robust Target Validation – What Does it Mean?
Registered attendees can view abstracts starting on 09/17/2018

Elizabeth A. Winzeler, University of California, San Diego, USA
Multi-Disciplinary approach to Target Identification, Validation and Prioritization in Plasmodium

Dirk Schnappinger, Weill Cornell Medical College, USA
Combining Chemical Probes and Genetic Knockdowns to Validate Drug Targets in Mycobacterium tuberculosis

Boris Striepen†, University of Pennsylvania, USA
Engineering Unculturable Cryptosporidium parvum for Drug Target Validation

Short Talk Chosen from Abstracts

12:00—13:30
On Own for Lunch

15:30—17:00
Networking and Welcome Mixer with Grand Challenges and Keystone Symposia

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.


FRIDAY, OCTOBER 19

08:30—11:30
Importance of Chemical Diversity in Seeking New Leads
Registered attendees can view abstracts starting on 09/17/2018

Ghotas Evindar†, GlaxoSmithKline, USA
Experience with DNA-Encoded Libraries in Search for New Leads against TB and Malaria

E. Paige Stout, Sirenas, USA
Application of Data-Mining and Deep Learning to Identify New Leads from Marine Natural Products

Coffee Break

Judy A. Sakanari, University of California, San Francisco, USA
Screening a Repurposing Library for Agents with Macrofilaricidal Activity

Charles E. Mowbray, Drugs for Neglected Diseases Initiative, Switzerland
A New Era of Orally Active Treatments for Leishmaniasis Patients

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

13:00—22:00
Poster Viewing

14:30—16:30
Workshop 1: Novel Clinical Trial Design

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—19:00
Alternative Approaches to Drug Delivery – Opportunities and Challenges
Registered attendees can view abstracts starting on 09/17/2018

Speaker to be Announced

Andrew Martin Bellinger†, Lyndra, USA
Development of Oral, Ultra Long-Lasting, Sustained Release Therapies in the Fight against Malaria and HIV

Arnab Chatterjee†, Calibr, USA
Chemoprophylaxis for Prevention of Malaria Infection

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 1


SATURDAY, OCTOBER 20

08:00—10:00
Poster Setup

10:00—17:00
Poster Viewing

08:30—11:30
Improving Target and Phenotypic-based Approaches
Registered attendees can view abstracts starting on 09/17/2018

Leann M. Tilley, University of Melbourne, Australia
The Proteasome as a Target for New Antimalarial Drugs

Kirsten Hanson, University of Texas, San Antonio, USA
Profiling Compounds against Liver Stage Malaria

Coffee Break

Deborah Hung†, Broad Institute, USA
Multiplex Screening of an M. tuberculosis Hypomorph Library Simultaneously Identifies Lead and Target

Marc Gitzinger†, BioVersys AG, Switzerland
A SMARt Approach to Reversing Drug Resistance in TB

Short Talk(s) Chosen from Abstracts

11:30—12:30
Lunch

12:00—14:30
Poster Session 2

14:30—16:30
Workshop 2: Opportunities for Repurposing to Discover New Candidates or Mature Starting Points

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—19:00
Translational Tools for Predicting Efficacy and Resistance
Registered attendees can view abstracts starting on 09/17/2018

Wesley C. Van Voorhis, University of Washington, USA
Pharmacodynamic Modeling of Anti-Cryptosporidium Drug Efficacy

Dyann F. Wirth†, Harvard School of Public Health, USA
Protecting New Anti-Malarial Compounds through Strategies that Suppress Emergence of Resistance

Christoph G. Lange†, Research Center Borstel, Germany
Identification of Biomarkers for Monitoring Clinical drug Efficacy

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.


SUNDAY, OCTOBER 21

 
Departure


*Session Chair †Invited, not yet responded.



We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Assistant Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676